- /
- Supported exchanges
- / US
- / HUMA.NASDAQ
Humacyte Inc (HUMA NASDAQ) stock market data APIs
Humacyte Inc Financial Data Overview
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. Humacyte, Inc. was founded in 2004 and is headquartered in Durham, North Carolina.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Humacyte Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Humacyte Inc data using free add-ons & libraries
Get Humacyte Inc Fundamental Data
Humacyte Inc Fundamental data includes:
- Net Revenue: 2 016 K
- EBITDA: -105 185 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-08
- EPS/Forecast: -0.122
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Humacyte Inc News
New
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Humacyte, Inc. (HUMA) closed at $0.66, marking a -1.28% move from the previous day. The stock's change was less than the S&P 500's daily loss of 0.19%. Elsewhere, the Do...
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know
Humacyte, Inc. (HUMA) ended the recent trading session at $0.71, demonstrating a +2.31% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain...
Here's Why Humacyte, Inc. (HUMA) Fell More Than Broader Market
Humacyte, Inc. (HUMA) closed at $0.62 in the latest trading session, marking a -11.14% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.01% for the day. Elsew...
Biggest stock movers: ORCL, HUMA, and more
[Abstract Finance Technology Concept] koto_feja Stock futures rose Thursday morning as markets staged a tentative recovery from Wednesday's steep AI-led sell-off. Market sentiment was further support...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.